Spinal Tech

NuVasive's Attrax Putty was shown to be an effective bone graft substitute for autograft in instrumented thoracolumbar posterolateral lumbar fusion.

A ribbon-cutting ceremony was held March 6 for Integrity implants' new 15,000-square-foot headquarters in Palm Beach Gardens, Fla., The Palm Beach Post reports.

Smith+Nephew CEO Roland Diggelmann is approaching his sixth month as head of the medical device company and turning his attention to the growing orthopedic ASC market this year.

Parvizi Surgical Innovation made a minority investment in Navbit Holdings, an Australian surgical devicemaker.

Here are two spine and orthopedic company transactions in the past month:

AcelRX Pharmaceuticals is partnering with Brigham and Women's Hospital in Boston to study the perioperative use of DSUVIA in the analgesic regimen for spine surgery.

The FDA provided Medacta clearance for its Mecta-C Stand Alone anterior cervical fusion device.

A royalties dispute between Medtronic and Carmel-based Indiana Spine Group founder Rick Sasso, MD, was returned to a state court March 4, The Indiana Lawyer reports.

Osteobiologics company Biogennix received FDA clearance March 5 for an expanded indication of its Agilon moldable bone grafting product.

The minimally invasive spinal implant market has growth in its sights, with the market projected to hit $6.49 billion by 2027, according to analysis by Reports and Data.